Sonnet BioTherapeutics (SONN.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow - Longbridge

Quote List Quote List

Event Tracking

Aug14

Sonnet BioTherapeutics released FY2025 Q3 earnings on August 13 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.9522 (forecast USD -0.49)

03:00

Sonnet BioTherapeutics released FY2025 9 Months Earnings on August 13 (EST), actual revenue USD 1 M, actual EPS USD -3.4049

03:00

Aug4

Sonnet BioTherapeutics Expanding Clinical Assessment of SON-1010 Combination Therapy for Ovarian Cancer

12:42

Jul18

Sonnet Biotherapeutics Holdings Inc. Completes Private Placement Exceeding NASDAQ Listing Requirement

20:31

Jul14

Monteverde Investigating Sonnet and Rorschach Merger

22:56

Sonnet BioTherapeutics Partners with Rorschach I LLC to Create Hyperliquid Strategies

10:58

Schedules & Filings

Schedules

Filings

Aug13

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -3.776 M, EPS -0.9522

May13

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -3.491 M, EPS -0.8902

Feb13

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 1 M, Net Income -3.161 M, EPS -1.5625

View More

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change

View More